Login

Clinical Trials for Special Populations - Dr. Robert Jacobson, a Professor of Pediatric and Adolescent Medicine 00:00:00

Share On Facebook Share On Twitter

Clinical Trials for Special Populations

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
AdAlta Phase I Extension Study Results - Tim Oldham, MD, Adalta Ltd
00:10:00
Bonterra Resources: Exploration and Development Update
00:00:00
MARC VOIGT Executive Director & Chief Executive Officer, Immutep Ltd
00:10:00
Northern Minerals at One-to-One Mining Investment Conference: Pioneering Rare Earths in Western Australia
00:10:00
Top Absolute Return Performers: Fatima Khizou’s Picks for Consistent Gains Across Market Cycles | Fatima Khizou - Fund Analyst, Morningstar
00:10:00
No more small boy spreadsheets, build your business|Elizabeth Yin,General Partner, Hustle Fund
00:10:00
Middle Market Infrastructure: H.I.G. Capital's Value-Driven Approach |Jack Macfarlane, Principal,  H.I.G. Capital.
00:10:00
Experts Discuss Bitcoin, Blockchain, and the U.S. Economy: Steven Ricchiuto and David Bailin
00:10:00
BIO-key's Periodic SEC Filings Offer Comprehensive Insights into Cybersecurity Expansion and Business Performance | Michael DePasquale, CEO, BIO-key International Inc.
00:10:00
Exploring Investment Opportunities and Market Trends in Various Sectors
00:10:00
GameStop Market Update: Unpacking the Latest Developments | Morgan Christen, CEO, Spinnaker Investment Group, LLC.
00:10:00
David Bramhill at 121 Oil & Gas Investment London: Insights into Union Jack Oil's Strategy and Market Position | David Bramhill, Executive Chairman, Union Jack Oil Plc.

© 2017 - Neuhu+